JP2025511409A5 - - Google Patents
Info
- Publication number
- JP2025511409A5 JP2025511409A5 JP2024559046A JP2024559046A JP2025511409A5 JP 2025511409 A5 JP2025511409 A5 JP 2025511409A5 JP 2024559046 A JP2024559046 A JP 2024559046A JP 2024559046 A JP2024559046 A JP 2024559046A JP 2025511409 A5 JP2025511409 A5 JP 2025511409A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- sequence described
- seq
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2204927.4 | 2022-04-04 | ||
| GBGB2204927.4A GB202204927D0 (en) | 2022-04-04 | 2022-04-04 | Cells expressing mesothelin |
| US202363482752P | 2023-02-01 | 2023-02-01 | |
| US63/482,752 | 2023-02-01 | ||
| PCT/IB2023/053431 WO2023194911A1 (en) | 2022-04-04 | 2023-04-04 | Cells expressing an anti-mesothelin car |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511409A JP2025511409A (ja) | 2025-04-15 |
| JP2025511409A5 true JP2025511409A5 (https=) | 2026-04-14 |
Family
ID=86328908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559046A Pending JP2025511409A (ja) | 2022-04-04 | 2023-04-04 | 抗メソテリンｃａｒを発現する細胞 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250025555A1 (https=) |
| EP (2) | EP4628504A3 (https=) |
| JP (1) | JP2025511409A (https=) |
| KR (1) | KR20240168982A (https=) |
| CN (1) | CN119110845A (https=) |
| AU (1) | AU2023250251A1 (https=) |
| CA (1) | CA3254719A1 (https=) |
| CL (2) | CL2024002948A1 (https=) |
| CO (1) | CO2024013343A2 (https=) |
| IL (1) | IL315660A (https=) |
| MX (1) | MX2024012314A (https=) |
| PE (1) | PE20242282A1 (https=) |
| TW (1) | TW202405164A (https=) |
| WO (1) | WO2023194911A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4504247A1 (en) | 2022-04-04 | 2025-02-12 | Gammadelta Therapeutics Ltd | Novel gene armoring |
| WO2025240496A1 (en) * | 2024-05-14 | 2025-11-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Natural killer cells expressing a mesothelin-targeted chimeric antigen receptor and interleukin-15 for the treatment of solid tumors |
| WO2026069206A1 (en) * | 2024-09-25 | 2026-04-02 | Takeda Pharmaceutical Company Limited | Hypoimmunogenic modified gamma delta t cells |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP1777294A1 (en) | 2005-10-20 | 2007-04-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins |
| US9272002B2 (en) * | 2011-10-28 | 2016-03-01 | The Trustees Of The University Of Pennsylvania | Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting |
| EP3783098A1 (en) * | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| US20200399383A1 (en) * | 2018-02-13 | 2020-12-24 | Novartis Ag | Chimeric antigen receptor therapy in combination with il-15r and il15 |
| TW202020145A (zh) * | 2018-07-13 | 2020-06-01 | 國立大學法人京都大學 | γδＴ細胞的製造方法 |
| WO2020172555A1 (en) * | 2019-02-21 | 2020-08-27 | Regents Of The University Of Minnesota | Genetically modified gamma delta t cells and methods of making and using |
| US20230159892A1 (en) * | 2020-04-06 | 2023-05-25 | Synthekine, Inc. | Engineered immune cells |
| US20230226181A1 (en) * | 2020-06-22 | 2023-07-20 | Nanjing Legend Biotech Co., Ltd. | GENETIC ENGINEERING OF gamma delta T CELLS FOR IMMUNOTHERAPY |
| JP7138989B1 (ja) * | 2020-08-04 | 2022-09-20 | セレンジーン インコーポレイテッド | メソテリンに特異的に結合する抗メソテリンキメラ抗原受容体 |
| JP2023540339A (ja) * | 2020-09-04 | 2023-09-22 | インパクト バイオ ユーエスエー インコーポレイテッド | 癌治療に使用するためのバイシストロン性阻害性キメラ抗原受容体（ｉＣＡＲ）／活性化キメラ抗原受容体（ａＣＡＲ）構築物 |
| GB202013962D0 (en) * | 2020-09-04 | 2020-10-21 | Gammadelta Therapeutics Ltd | Immunotherapy composition |
-
2023
- 2023-04-04 CN CN202380032086.3A patent/CN119110845A/zh active Pending
- 2023-04-04 EP EP25175873.6A patent/EP4628504A3/en active Pending
- 2023-04-04 KR KR1020247032909A patent/KR20240168982A/ko active Pending
- 2023-04-04 WO PCT/IB2023/053431 patent/WO2023194911A1/en not_active Ceased
- 2023-04-04 JP JP2024559046A patent/JP2025511409A/ja active Pending
- 2023-04-04 PE PE2024002150A patent/PE20242282A1/es unknown
- 2023-04-04 EP EP23721778.1A patent/EP4504344A1/en active Pending
- 2023-04-04 IL IL315660A patent/IL315660A/en unknown
- 2023-04-04 CA CA3254719A patent/CA3254719A1/en active Pending
- 2023-04-04 AU AU2023250251A patent/AU2023250251A1/en active Pending
- 2023-04-06 TW TW112112882A patent/TW202405164A/zh unknown
-
2024
- 2024-09-30 CO CONC2024/0013343A patent/CO2024013343A2/es unknown
- 2024-10-01 CL CL2024002948A patent/CL2024002948A1/es unknown
- 2024-10-03 MX MX2024012314A patent/MX2024012314A/es unknown
- 2024-10-04 US US18/906,842 patent/US20250025555A1/en not_active Abandoned
-
2025
- 2025-07-25 CL CL2025002218A patent/CL2025002218A1/es unknown